Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
0.538
-0.001 (-0.19%)
Feb 21, 2025, 4:00 PM EST - Market closed
HSDT Employees
Helius Medical Technologies had 22 employees as of December 31, 2023. The number of employees decreased by 4 or -15.38% compared to the previous year.
Employees
22
Change (1Y)
-4
Growth (1Y)
-15.38%
Revenue / Employee
$22,818
Profits / Employee
-$402,682
Market Cap
2.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
HSDT News
- 4 weeks ago - Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study - GlobeNewsWire
- 4 weeks ago - Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - GlobeNewsWire
- 2 months ago - Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System - GlobeNewsWire
- 3 months ago - Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device - GlobeNewsWire
- 4 months ago - Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece - GlobeNewsWire
- 6 months ago - Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 months ago - Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire